Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Reports Increased Revenues, Widened Loss in Q4; Eyes Profitability in Q4 02

NEW YORK, Jan. 30 - Transgenomic on Wednesday said that its fourth-quarter losses widened as increased sales of its gene analysis equipment and chemicals failed to counter a jump in operating expenses.

Revenue swelled 51 percent to $10.7 million from $7.1 million one year ago, the company said.

Net loss for the period ended Dec. 31 widened to $2.7 million, or 12 cents a share, from $374,000, or 2 cents a share, year over year. 
 

Transgenomic also posted a 62 percent hike in revenues for fiscal 2001 to $38.5 million from $23.7 million in 2000. The firm also posted a net loss $7.4 million, or $0.33 per share, in fiscal 2001, compared with a loss of $8.6 million, or $0.52 per share, in 2000.

"We expect our total revenues to increase in the range of 45 percent to 55 percent this year," said Greg Duman, Transgenomic's chief financial officer. "The growing synthetic nucleic acids business is a significant component in meeting the company's overall revenue growth targets for 2002.

 

"Our 2002 plans project profitability in the fourth quarter of this year," he added.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.